SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001601830-23-000023
Filing Date
2023-05-08
Accepted
2023-05-08 08:22:37
Documents
69
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q rxrx-20230331.htm   iXBRL 10-Q 949863
2 EX-31.1 exhibit311-q0123.htm EX-31.1 7481
3 EX-31.2 exhibit312-q0123.htm EX-31.2 7469
4 EX-32.1 exhibit321-q0123.htm EX-32.1 3376
10 rxrx-20230331_g1.jpg GRAPHIC 107222
11 rxrx-20230331_g2.jpg GRAPHIC 142087
  Complete submission text file 0001601830-23-000023.txt   5802403

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rxrx-20230331.xsd EX-101.SCH 38953
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rxrx-20230331_cal.xml EX-101.CAL 63851
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rxrx-20230331_def.xml EX-101.DEF 191408
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rxrx-20230331_lab.xml EX-101.LAB 525052
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rxrx-20230331_pre.xml EX-101.PRE 326272
63 EXTRACTED XBRL INSTANCE DOCUMENT rxrx-20230331_htm.xml XML 733596
Mailing Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101
Business Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101 (385) 269-0203
RECURSION PHARMACEUTICALS, INC. (Filer) CIK: 0001601830 (see all company filings)

IRS No.: 464099738 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40323 | Film No.: 23895951
SIC: 2836 Biological Products, (No Diagnostic Substances)